Related Experiment Video
Updated: Aug 4, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Preleukemic states in children with acute lymphoblastic leukemia
Cancer
|July 1, 1981
Summary
Childhood acute lymphoblastic leukemia can present with preleukemic states, often manifesting as hypoplastic anemias. These anemias may resolve spontaneously or with treatment, but can indicate an underlying preleukemic condition.
Area of Science:
- Pediatric Hematology
- Oncology
- Hematologic Malignancies
Background:
- Acute lymphoblastic leukemia (ALL) is the most common childhood cancer.
- Preleukemic states can precede overt leukemia development.
- Understanding early indicators of ALL is crucial for timely diagnosis and intervention.
Observation:
- Two cases of childhood ALL presenting with preleukemic states are detailed.
- A review of 13 additional literature cases is included.
- Hypoplastic anemias were the most frequent preleukemic manifestation observed.
Findings:
- Preleukemic states in childhood ALL commonly present as hypoplastic anemias.
- These anemias may exhibit transient spontaneous resolution.
- Steroid therapy can also lead to temporary resolution of hypoplastic anemias.
- Acquired hypoplastic anemias, even with resolution, may signify an underlying preleukemic phase.
Implications:
- Early recognition of hypoplastic anemias in children is vital for diagnosing preleukemic states.
- This understanding can improve diagnostic pathways for childhood acute lymphoblastic leukemia.
- Identifying preleukemic conditions allows for earlier therapeutic strategies in pediatric oncology.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...